Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Evgen Pharma ( (GB:TCF) ).
TheraCryf PLC, a company involved in the pharmaceutical industry, has announced a change in its voting rights structure due to an acquisition or disposal of shares. Andrew Leach has crossed a significant threshold in voting rights, now holding 3.7565% of the total voting rights as of March 11, 2025. This change has been officially notified to the issuer on March 12, 2025, potentially impacting the company’s governance and shareholder dynamics.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For a thorough assessment of TCF stock, go to TipRanks’ Stock Analysis page.